Prohost Portfolio PLUS #3
CureVac N.V.

We were looking forward to learning more important details about the German firm, CureVac N.V. (CVAC), when the company announced business updates and financial results for its fourth quarter and full-year 2020. The reason for our interest was the fact that the U.S. was looking to take over this firm two years ago to no avail. A more important reason was that its products and vaccines are based on the mRNA creation and usage – the same technology that helped to create the COVID-19 vaccines . . .